Gene · 6428
Papers2,106
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,106
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction and validation of a prognostic model of pyroptosis related genes in hepatocellular carcinoma. | Front Oncol | 2022 | 36338707 | PubTator, text mining | PubMed |
| Investigation of the effect of SRSF9 overexpression on HIV-1 production. | BMB Rep | 2022 | 36330710 | PubTator, text mining | PubMed |
| Chemotherapy induces feedback up-regulation of CD44v6 in colorectal cancer initiating cells through β-catenin/MDR1 signaling to sustain chemoresistance. | Front Oncol | 2022 | 36330477 | PubTator, text mining | PubMed |
| Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications. | J Hematol Oncol | 2022 | 36319992 | PubTator, text mining | PubMed |
| Current insights into the regulation of programmed cell death by TP53 mutation in cancer. | Front Oncol | 2022 | 36313700 | PubTator, text mining | PubMed |
| Scoring model based on the signature of non-m6A-related neoantigen-coding lncRNAs assists in immune microenvironment analysis and TCR-neoantigen pair selection in gliomas. | J Transl Med | 2022 | 36309750 | PubTator, text mining | PubMed |
| MICALL2 as a substrate of ubiquitinase TRIM21 regulates tumorigenesis of colorectal cancer. | Cell Commun Signal | 2022 | 36307841 | PubTator, text mining | PubMed |
| ESRP1-regulated isoform switching of LRRFIP2 determines metastasis of gastric cancer. | Nat Commun | 2022 | 36307405 | PubTator, text mining | PubMed |
| Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision Medicine. | Int J Mol Sci | 2022 | 36293493 | PubTator, text mining | PubMed |
| mTOR Contributes to the Proteome Diversity through Transcriptome-Wide Alternative Splicing. | Int J Mol Sci | 2022 | 36293270 | PubTator, text mining | PubMed |
| Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities. | Cancer Commun (Lond) | 2022 | 36266736 | PubTator, text mining | PubMed |
| SRSF5-Mediated Alternative Splicing of M Gene is Essential for Influenza A Virus Replication: A Host-Directed Target Against Influenza Virus. | Adv Sci (Weinh) | 2022 | 36257906 | PubTator, text mining | PubMed |
| RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer. | Adv Drug Deliv Rev | 2022 | 36252617 | PubTator, text mining | PubMed |
| A new machine learning method for cancer mutation analysis. | PLoS Comput Biol | 2022 | 36251702 | PubTator, text mining | PubMed |
| Expanded targeting scope of LbCas12a variants allows editing of multiple oncogenic mutations. | Mol Ther Nucleic Acids | 2022 | 36250202 | PubTator, text mining | PubMed |
| Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patients. | Front Genet | 2022 | 36246627 | PubTator, text mining | PubMed |
| Crosstalk among N6-methyladenosine modification and RNAs in central nervous system injuries. | Front Cell Neurosci | 2022 | 36246528 | PubTator, text mining | PubMed |
| Prediction of prognosis, immune infiltration and immunotherapy response with N6-methyladenosine-related lncRNA clustering patterns in cervical cancer. | Sci Rep | 2022 | 36241866 | PubTator, text mining | PubMed |
| SRSF3 Restriction Eases Cervical Cancer Cell Viability and Metastasis via Adjusting PI3K/AKT/mTOR Signaling Pathway. | Contrast Media Mol Imaging | 2022 | 36237584 | PubTator, text mining | PubMed |
| The Emerging Roles and Clinical Potential of circSMARCA5 in Cancer. | Cells | 2022 | 36231036 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6428/papers?page=20